It will be only determined based on additional details: Drug substance or Drug Product, dosage form type, stability data, testing method, etc...
------------------------------
Gaurang Bhavsar, MS, RAC
Manager, R&D and RA
Sunrise Pharmaceutical, Inc.
Rahway, NJ 07065
USA
------------------------------
Original Message:
Sent: 28-May-2018 17:06
From: Anonymous Member
Subject: Periodic or skip testing
This message was posted by a user wishing to remain anonymous
Dear All
Would you please confirm the submission classification for the change from the batch-to-batch analysis to a pre-selected batches
and / or at predetermined intervals assuming that historical data evaluated and no concerns.